Actos Bladder Cancer Types
There are three bladder cancer cell classifications, all named for the cell type that becomes cancerous:
Transitional cell carcinoma, involving the cells in the innermost layer of the bladder lining, accounts for about 90 percent of all bladder cancers. This type is the easiest to detect, but prognosis varies with the aggressiveness of the cancer.
Squamous cell carcinoma, involving thin flat cells that form in the bladder lining in response to a long-term infection or irritation, accounts for 8 percent of all bladder cancers. Because it tends to be found in later stages, the prognosis is poor.
Adenocarcinoma occurring in the cells making up the mucus-secreting glands in the bladder in the presence of long-lasting irritation or inflammation, accounts for 2 percent of all bladder cancers. Prognosis is poor, as it tends to be found in its later stages.
Actos Users Should Get Acquainted with Bladder Cancer Facts!
If you've ever used Actos (pioglitazone) to treat your type 2 diabetes, you should educate yourself about this disease. That's because preliminary results from a 10-year study show Actos users had a 40 percent higher bladder cancer risk. (See Actos side effects.) To learn more about bladder cancer cell types, as well as the latest treatment options, simply request a free copy of the book100 Questions & Answers About Bladder Cancer now!